Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pelvic floor muscle fibers are specialized skeletal muscle fibers that form the core contractile units of the pelvic floor muscles, a group of striated muscles and associated connective tissues at the base of the pelvis[1][3][5][7][8]. Collectively, these muscles—most notably the levator ani complex (pubococcygeus, puborectalis, iliococcygeus) and coccygeus—support pelvic organs (bladder, bowel, reproductive organs), maintain continence, participate in childbirth, and contribute to sexual function[1][3][5][7][8]. The fibers themselves are not considered therapeutic targets like a receptor or enzyme; rather, disorders associated with these muscles (e.g., pelvic organ prolapse, incontinence, dysfunction following injury) are clinical targets for rehabilitation or surgical therapies[1][3][7][8]. Pelvic floor muscle fibers consist primarily of type I (slow-twitch, fatigue-resistant) and type II (fast-twitch) fibers to provide sustained support and rapid contraction when necessary[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pelvic floor muscle fiber.